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Hepatic Vein Flow Index During Orthotopic Liver
Transplantation as a Predictive Factor for Postoperative
Early Allograft Dysfunction
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Shunji Nagai, MD, PhDz, Ahmad Itani, MDx, Michael Isley, MDx,
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Objectives: The authors devised a hepatic vein flow index (HVFi), using intraoperative transesophageal echocardiography and graft weight, and
investigated its predictive value for postoperative graft function in orthotopic liver transplant.
Design: Prospective clinical trial.
Setting,: Single-center tertiary academic hospital.
Participants: Ninety-seven patients who had orthotopic liver transplant with the piggy-back technique between February 2018 and December 2019.
Measurements and Main Results: HVFi was defined with HV flow/graft weight. Patients who developed early graft dysfunction (EAD) had low
HVFi in systole (HVFi sys, 1.23 v 2.19 L/min/kg, p < 0.01), low HVFi in diastole (HVFi dia, 0.87 v 1.54 L/min/kg, p < 0.01), low hepatic vein
flow (HVF) in systole (HVF sys, 2.04 v 3.95 L/min, p < 0.01), and low HVF in diastole (HVF dia, 1.44 v 2.63 L/min, p < 0.01). More cardiac
death, more vasopressors at the time of measurement, more acute rejection, longer time to normalize total bilirubin (TIME t-bil), longer surgery
time, longer neohepatic time, and more packed red blood cell transfusion were observed in the EAD patients. All HVF parameters were negatively correlated with TIME t-bil (HVFi sys R = 0.406, p < 0.01; HFVi dia R = 0.442, p < 0.01; HVF sys R = 0.44, p < 0.01; HVF dia
R = 0.467, p < 0.01). The receiver operating characteristic curve analysis determined the best cut-off levels of HVFi to predict occurrence of
EAD (HVFi sys <1.608, HVFi dia <0.784 L/min/kg), acute rejection (HVFi sys <1.388, HVFi dia <1.077 L/min/kg), and prolonged high total
bilirubin (HVFi sys <1.471, HVFi dia <1.087 L/min/kg).
Conclusions: The authors’ devised HVFi has the potential to predict the postoperative graft function.
Ó 2021 Elsevier Inc. All rights reserved.
Key Words: early allograft dysfunction; piggy-back technique; orthotopic liver transplant; hepatic vein flow; transesophageal echocardiography

This study was conducted at Henry Ford Hospital, then Y.M. was relocated
to University of Maryland.
Y. Morita contributed the study for designing the study and manuscript writing. T. Kariya contributed for statistical analysis and helped with manuscript
writing. A. Itani, M. Isley, and S. Nagai contributed for data gathering, and
helped with manuscript writing. K. Tanaka contributed for manuscript writing.
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LIVER TRANSPLANTATION (LT) continues to be the
gold standard for treating end-stage liver disease (ESLD), and
the piggy-back technique has been widely used for orthotopic
LT (OLT) since its introduction in 1989, mostly because of
more stable intraoperative hemodynamics.1,2 Outflow obstruction of the liver graft is a well-reported complication of the
piggy-back technique, and may lead to allograft dysfunction,
graft loss, and death.2,3
Intraoperative anesthetic management in LT can be challenging due to preoperative medical comorbidities, significant

https://doi.org/10.1053/j.jvca.2020.12.034
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intraoperative hemodynamic changes, and periodic unexpected
findings, such as intracardiac thrombi or pulmonary emboli;4,5 and
the usefulness of intraoperative transesophageal echocardiography
(TEE) has been discussed in previous publications.1,6,7 Although
TEE use during LT can aid in the diagnosis and management of
hemodynamic instability and is recommended in the practice
guidelines from the American Society of Echocardiography
(ASE)/Society of Cardiovascular Anesthesiologists (SCA) and the
American Association for the Study of Liver,8-10 its routine intraoperative use has limited scientific support.6,7 Actually, TEE is relatively contraindicated in grade 3 or recently bleeding esophageal
varices, which are common in ESLD, and the possibility for complications should not be ignored.11-13 However, the biggest argument is that TEE findings can provide only a clinical impression,
which is subjective to interobserver variability, although there is
no doubt TEE provides important hemodynamic information.1,7,14
An increasing number of reports show the usefulness of TEE to
detect procedure-related complications, such as graft hepatic vein
(HV) or inferior vena cava (IVC) stenosis.6,10,15,16 However, no
published study has performed the quantitative assessment of graft
flow using intraoperative TEE. Because HV can be assessed with
TEE, TEE-derived HV flow parameters have a potential to detect
early allograft dysfunction (EAD) sooner and guide therapy to
optimize the graft function. HV is the outflow of graft flow and
can be an index of graft perfusion. Also, HV flow can be calculated using intraoperative TEE measurements. The authors’ group
recently demonstrated that hepatic vein flow index (HVFi), which

was defined as TEE-measured HV flow/graft weight, potentially
had good predictive value for postoperative EAD in piggy-back
OLT patients.17 The current study used the same methodology for
calculating HVFi as the authors’ previous retrospective study. The
differences were (1) the current study was a prospective design,
whereby HVFi was calculated before outcome data collection,
and (2) the current study sought to demonstrate reproducibility of
the HVFi score by means of intra-rater and inter-rater variances.
Methods
Study Design
This study was approved by the Henry Ford Health System
Institutional Review Board (IRB #12156), and written consent
was obtained before enrolling the patients. Also, this study
was registered in ClinicalTrials.gov (NCT03814031).
This was a prospective, observational study of a cohort of
adult patients who underwent OLT using the piggy-back technique between February 2018 and December 2019 at the
Henry Ford Hospital in Detroit, Michigan. TEE data were collected from intraoperative TEE images as part of a prospective
echocardiographic protocol measuring two-dimensional TEEcalculated hepatic vein flow (HVF) using transgastric modified
HV view (Fig 1). In order to obtain the transgastric modified
HV view, insert the probe into the stomach, find the transgastric basal view, rotate the probe right, identify the IVC as a

Fig. 1. Transgastric inferior vena cava view with hepatic vein velocity measurement.
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large vascular structure in the liver, withdraw the probe to
image drainage of the IVC into the right atrium, and adjust the
omniplane angle (0˚-40˚) to image the HV as it drains into the
IVC.
The patients’ demographics, perioperative clinical information, and postoperative outcomes were collected from the
authors’ computerized patient database.
Patient Cohort
Inclusion criteria were adult patients undergoing the OLT
piggy-back technique with TEE-measured HV flow between
February 2018 and December 2019. Exclusion criteria were
patient refusal to participate in the study, absolute TEE contraindication, inability to acquire appropriate images for HV flow
measurement, or unavailability of a cardiac trained anesthesiologist.
All patients received general anesthesia with endotracheal
intubation, standard American Society of Anesthesiologists
monitoring, arterial blood pressure monitoring, central venous
pressure monitoring, pulmonary artery pressure monitoring,
and comprehensive TEE examination with designated protocol. Intraoperative anesthetics, mechanical ventilation, vasopressor, inotropic, and fluid/transfusion management were
performed based on department protocol such as to maintain
mean arterial pressure >65 mmHg, tidal volume 6-8 mL/ideal
body weight (kg), positive end-expiratory pressure at 5-to-7
cmH2O.
Data Collection
TEE images were collected intraoperatively by National
Board of Echocardiography-certified advanced perioperative
echocardiographers using an iE33 echocardiographic machine
with an X7 TEE probe (Philips Medical Systems, Andover,
MA), and were stored in Syngo Workflow (Siemens Medical
Solution, Malvern, PA). Timing for acquiring TEE modified
transgastric HV view was in the neohepatic phase before fascia
closure. To obtain HV flow, the pulsed-wave Doppler (PWD)
sample volume was set in the graft HV just distal to IVC-graft
anastomosis where an acceptable flow envelope was obtained.
Echocardiography Parameters
Three investigators (A, B, and C), who were also National
Board of Echocardiography-certified advanced perioperative
echocardiographers, measured HVF in systole and diastole
independently using TEE images, which were acquired by a
single cardiac anesthesiologist (advanced TEE boarded). The
authors calculated HVF as follows: HVF (L/min) = HV area
(cm2) x HV max velocity (cm/s) in systole and diastole x 60/
1000, where HV area (cm2) = square of HV radius (cm) x 3.14,
and HV max velocity (cm/s) was measured by TEE PWD with
sample volume selected in the HV (Fig 1), where diameter of
HV was measured as well. Efforts were made to align PWD
and HV. The authors defined HVFi as HVF/donor liver weight
(kg). The authors adjusted HVF with graft weight because

3

recently it is more common to assess graft flow with graft
size.18 To minimize selection bias, all the investigators were
blinded to the hypothesis of the study.
Outcomes
The primary outcome was EAD, which was defined by the
presence of one or more of the following: total bilirubin (t-bil)
10 mg/dL (171 mmol/L), or INR 1.6 on day 7, and ALT/
AST >2,000 IU/L within the first seven days.19,20 The secondary outcome was acute rejection within six-to-eight weeks
after transplant, prolonged (>seven days) time to normalize
total bilirubin (TIME t-bil), prolonged (>seven days) time to
normalize INR (TIME inr), and prolonged (>seven days) time
to normalize platelet count (TIME plt).
Statistical Analysis
For continuous variables, the normality test was performed
using the Kolmogorov-Smirnov test. Continuous variables
with normal distribution were displayed as mean § standard
deviation, and those with non-normal distribution were displayed as median and interquartile range. Categorical variables
were presented as proportions and absolute numbers. The differences between the two groups were investigated using
unpaired and paired Student t tests or the Mann-Whitney U
test. The Chi-square or Fisher exact test was used for categorical variables. A correlation analysis was performed for HVFi
and the times including TIME t-bil, TIME inr, and TIME plt
(Spearman as non-normal distribution). Also, Youden’s index
was used for receiver operating characteristic (ROC) curve
analysis to evaluate the appropriate cut-off value of HVFi for
predicting EAD, acute rejection, and prolonged TIME t-bil
(>seven days). The authors also performed subgroup risk
adjustment analysis in the cardiac death group with bivariate
analysis. Intrarater and inter-rater reliability analyses of HVFi
were performed using intraclass correlation coefficient
(ICC).21-23 The authors randomly picked 30 images and
obtained consistency ICC for interobserver variability using
all 3three investigators (A, B, and C) and absolute-agreement
ICC for intraobserver variability using investigator C, who
measured all images twice with an interval of six-to-eight
weeks.23 For interobserver variability, three investigators post
hoc determined HV diameter, peak systolic flow, and peak diastolic flow based on the PWD signal. All statistical analyses
were performed using R (The R Foundation for Statistical
Computing, Vienna, Austria. ver 4.0.2). All p values of less
than 0.05 were considered statistically significant.
Sample Size Calculation
Assuming incidence of EAD was 23.2% (range of incidence
was 2%-23%),19,20 70 patients in control and 21 patients in
EAD were needed at the power of 80% and alpha 0.05 with
achieving at least 0.7 for area under curve in ROC analysis. To
be conservative and account for potential problems with imaging analysis, 97 patients were enrolled.
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Results
Of the 120 eligible patients, 97 participated in the study
(patient refusal to participate in the study: two patients, absolute TEE contraindication: five patients, damping of the HVs
images: six patients, and technically challenging to obtain
appropriate views for HVF measurement: ten patients). No turbulent flow was observed in HV in the authors’ cohort. The
characteristics of these 97 patients are shown in Tables 1
and 2. No significant gastrointestinal bleeding was reported in
the authors’ study. The median HVFi in the EAD group was
significantly lower than the median HVFi in the non-EAD
group. In addition, the best cut-off levels to predict EAD for
HVFi sys was 1.608 and HVFi dia 0.784. Patients who developed EAD had low HVFi in systole (HVFi sys, 1.23 v 2.19
L/min/kg, p < 0.01), low HVFi in diastole (HVFi dia, 0.87
v 1.54 L/min/kg, p < 0.01), low HVF in systole (HVF sys,
2.04 v 3.95 L/min, p < 0.01), and low HVF in diastole (HVF
dia, 1.44 v 2.63 L/min, p < 0.01). More cardiac death, more
vasopressors at the time of measurement, more acute rejection,
longer TIME t-bil, longer surgery time, and more packed red
blood cell transfusion were observed in the EAD patients
(Table 1). Correlation coefficients between HVFs and graft
function index, such as TIME t-bil, TIME inr, and TIME plt,
are shown in Table 3. All HVF parameters were correlated
negatively with TIME t-bil (HVFi sys R = 0.406, p < 0.01;
HFVi dia R = 0.442, p < 0.01; HVF sys R = 0.44, p <
0.01; HVF dia R = 0.467, p < 0.01). The scatter plot is
shown in the EAD and non-EAD groups in Figure 2. The
ROC curve analysis and Youden criterion determined the best
cut-off levels of HVFis to predict occurrence of EAD (HVFi
sys <1.608, HVFi dia <0.784 L/min/kg; Fig 3, A), acute rejection (HVFi sys <1.388, HVFi dia <1.077 L/min/kg; Fig 3, B),
and prolonged high t-bil (HVFi sys <1.471, HVFi dia <1.087
L/min/kg; Fig 3, C). HVFi was superior to HVF in terms of
predicting these outcomes. Subgroup risk adjustment by bivariate analysis in the cardiac death group is shown in Table 4.
The authors chose donor age, model for end-stage liver disease
(MELD), cold ischemic time (CIT), and warm ischemic time
(WIT) as references based on previously reported risk factors
for EAD.19 The ICCs for the inter- and intraobserver analyses
of HVFi were high both in HVFi sys (inter-rater 0.997, intrarater 0.998) and HVFi dia (inter-rater 0.993, intrarater 0.998;
Table 5).

Table 1
Patient Demographics in EAD and Non-EAD Group

Donor Variables
Age (y)
Female
DCD
Liver weight (kg)
Recipient and
Surgical
Variables
Age (y)
Female
MELD
HTN
DM
NASH
Alcoholic
HCC
Hepatitis C
Acute rejection
Time to normal tbil (d)
Time to normal
INR (d)
Time to normal
platelet (d)
CIT (min)
WIT (min)
Op time (min)
Hepatectomy time
(min)
Anhepatic time
(min)
PRBC (unit)
FFP (unit)
Platelet (unit)
Cryoprecipitate
(unit)
Cell savor (mL)
Crystalloid (mL)
Colloids (mL)
UOP (mL)
EBL (mL)

EAD (n = 26)

No EAD (n = 71)

p Value

49 [40, 54.5]
15 (57.7%)
9 (34.6%)
1.73 [1.6, 2.1]

41 [29, 54]
33 (46.5%)
4 (5.63%)
1.7 [1.55, 1.90]

0.84
0.37
<0.001
0.32

58 [45, 64.5]
11 (42.3%)
22.5 [18, 28.8]
15 (57.7%)
10 (38.5%)
7 (26.9%)
4 (15.4%)
2 (7.7%)
0 (0%)
8 (30.8%)
16 [10, 32]

55 [50.8, 64]
28 (39.4%)
26 [17, 29]
28 (39.4%)
15 (21.1%)
13 (18.3%)
16 (22.5%)
5 (7.0%)
3 (4.2%)
5 (7.0%)
5.5 [1, 20]

0.81
0.82
0.69
0.166
0.115
0.40
0.576
1.0
0.562
<0.01
<0.01

7 [5 to 9]

5 [4 to 7]

0.1

10 [8 to 13]

10 [8 to 12]

0.86

306.5 [281.5,
345.8]
36.5 [29.3, 41]
415.0 [346.5,
472.8]
95 [65, 101]

281.0 [246, 328]

0.08

33 [27, 44.5]
347 [300.5, 389.5]

0.50
0.001

84 [55, 104]

0.27

78 [60.0, 95]

70 [62, 83]

0.27

4 [2, 9]
7 [2.25, 12]
0.5 [0, 2]
1 [0, 2]

3 [0, 5]
4 [2, 7.5]
0 [0, 1]
0 [0, 2]

0.02
0.06
0.19
0.31

675 [450, 1325]
4000 [2625, 6175]
700 [500, 1000]
525 [415, 966]
1100 [1000, 2000]

450 [225, 675]
3200 [2000, 4400]
750 [500, 1200]
477 [321, 882.5]
1500 [1000 to
2200]

0.06
0.09
0.67
0.44
0.67

Discussion

Abbreviations: CIT, cold ischemic time; DCD, donor of cardiac death; DM,
diabetes mellitus; EAD, early allograft dysfunction; EBL, estimated blood
loss; FFP, fresh frozen plasma; HCC, hepatocellular carcinoma; HTN,
hypertension; MELD, model for end-stage liver disease; NASH, nonalcoholic
steatohepatitis, PRBC, packed red blood cells; UOP, urine output; WIT, warm
ischemic time.

The authors’ presented prospective observational study
showed that HVFi and HVF obtained from intraoperative TEE
were related to the postoperative graft function of OLT. HVF
and HVFi were lower in patients with EAD and negatively correlated with the time to bilirubin normalization after the procedure. Lower HVFis were risk factors for EAD after
adjustments with donor age, MELD, CIT, or WIT. ROC analyses revealed the cut-off values of HVFis to predict EAD, acute
rejection, and prolonged high t-bil with fair sensitivity and
specificity. HVFi was superior to HVF regarding these

predictions because graft weight adjustment might have led to
assess blood flow in each segment.18
In addition to intraoperative TEE’s widely recognized purpose as a hemodynamic monitor in OLT, the benefits of assessing graft anastomosis patency with TEE qualitatively also have
been reported.6,10,15,16 This study was novel in that the authors
quantitatively assessed HV flow and its correlation with postoperative graft function in the piggy-back technique. TEE is
not without associated complications in ESLD, which include
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Table 2
Hepatic Vein Parameters in EAD and Non-EAD Group

HV flow systolic index
(L/min/kg)
HV flow diastolic index
(L/min/kg)
HV flow systolic (L/min)
HV flow diastolic (L/min)
Portal vein flow (L/min)
Hepatic artery flow (L/min)
MAP at the time of
measurement (mmHg)
CI at the time of
measurement (L/min/
m2)
More than 1 vasopressor
at the time of
measurement

Table 3
Spearman’s Correlation Coefficients Between HVF and Graft Function Index

EAD (n = 26)

No EAD (n = 71) p Value

1.23 [0.85, 1.73]

2.19 [1.28, 3.70]

< 0.001

0.87 [0.62, 1.32]

1.54 [1.07, 2.34]

< 0.001

2.04 [1.38, 3.03]
1.44 [1.02, 2.20]
1.27 [1.1, 1.5]
0.32 [0.2, 0.44]
65 [56.25, 70.25]

3.95 [2.02, 6.40]
2.63 [1.69, 4.13]
1.5 [1.2, 1.78]
0.35 [0.21, 0.59]
67 [62.0, 76.5]

0.0035
0.0015
0.34
0.51
0.16

4.6 [3.28, 5.52]

0.587

4.86 [3.8, 5.85]

22 (84.6%)

38 (53.5%)

5

< 0.01

NOTE. Vasopressors include vasopressin (0.01-0.03 unit/min) or
norepinephrine (0.02-0.08 mg/kg/min).
Abbreviations: CI, cardiac index; EAD, early allograft dysfunction; HV,
hepatic vein; MAP, mean arterial pressure.

esophageal varices and coagulopathy, and its benefits and risks
should be weighed on a case-by-case basis.6,7 The ASE/SCA
now recommends that images of the IVC and HVs be obtained
as part of a comprehensive perioperative assessment,8 and its
value has been corroborated in several case reports6,10,16,24-26
The modified HV view described in this study is not part of
the basic TEE certification endorsed by the ASE/SCA,8,27 and
its utility has not been investigated widely in OLT. The authors

HVFi sys
HVFi dia
HVF sys
HVF dia

TIME t-bil (d)

TIME inr (d)

TIME plt (d)

0.406 (p < 0.01)
0.442 (p < 0.01)
0.44 (p < 0.01)
0.467 (p < 0.01)

0.143 (p = 0.177)
0.142 (p = 0.179)
0.15 (p = 0.157)
0.139 (p = 0.189)

0.192 (p = 0.068)
0.0037 (p = 0.972)
0.194 (p = 0.066)
0.11 (p = 0.3)

Abbreviations: HVF, hepatic vein flow; HVFi dia, hepatic vein flow index in
diastole; HVFi sys, hepatic vein flow index in systole; TIME inr, time to
normalize INR; TIME plt, time to normalize platelet; TIME t-bil, time to
normalize total bilirubin.

believe that this is partly because of transplant anesthesiologists’ unfamiliarity with obtaining this view. At the
authors’ institute, three out of the six transplant anesthesiologists are cardiac trained and readily available for acquiring
necessary images, which might have led to a greater percentage of success in obtaining this view.
In previous studies, assessment of HV mostly has been done
with perioperative transabdominal Doppler ultrasound, but
mostly on waveform assessment. Britton, et al. reported damping of the HV signal, with Doppler ultrasound, as the first indication of rejection after pediatric LT.28 The authors observed
damping of the HV images in six patients, three of whom had
acute rejection. Recently, Vetrugno et al. reported the importance of paying attention to HV-flow Doppler waveform by
referring to detailed explanations on HV Doppler waveform.10,29 Although Doppler ultrasound has the advantage of
being able to identify flows in each HV, TEE comprehensively
is able to assess HV flow, volume status, and cardiac function.

Fig. 2. Scatter plot distribution of HVF index in EAD and non-EAD group. (A) HVF systolic index grouped by EAD presence. (B) HVF diastolic index grouped by
EAD presence. Note that each red box shows median 25 percentile and median 75 percentile in each group. Abbreviations: EAD, early allograft dysfunction; HVF,
hepatic vein flow.
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Fig. 3. (A). ROC curve analysis and Youden criterion to predict occurrence of EAD, HVFi sys <1.608 provides 53.5% specificity and 96.2% sensitivity in predicting EAD, while HVFi dia <0.784 provides 74.6% specificity and 65.4% sensitivity in predicting EAD (AUC 0.72 [95% CI 0.614-0.826] v 0.738 [95% CI 0.6340.845], p = 0.425). AUC, area under the curve; CI, confidence interval; ROC, receiver operating characteristic.
(B). ROC curve analysis and Youden criteria to predict occurrence of acute rejection, HVFi sys <1.388 provides 56.0% specificity and 100% sensitivity in predicting acute rejection, while HVFi dia <1.077 provides 51.2% specificity and 100% sensitivity in predicting acute rejection (AUC 0.722 [95% CI 0.619-0.825] v
0.711[95% CI 0.6-0.821], p = 0.665) AUC, area under the curve; CI, confidence interval; HVFi dia, hepatic vein flow index in diastole; HVFi sys, hepatic vein
flow index in systole; ROC, receiver operating characteristic.
(C). ROC curve analysis and Youden criteria to predict occurrence of prolonged TIME t-bil (TIME t-bil >7 days) HVFi sys <1.471 provides 71.1% specificity
and 76.9% sensitivity in prolonged t-bil, while HVFi dia<1.087 provides 68.9 % specificity and 78.8 % sensitivity in prolonged t-bil (AUC 0.703 [95% CI 0.5950.812] v 0.738 [95% CI 0.638-0.839], p = 0.128) AUC, area under the curve, EAD, early allograft dysfunction; HVFi dia, hepatic vein flow index in diastole;
HVFi sys, hepatic vein flow index in systole; ROC: receiver operating characteristic, TIME t-bil: time to normalize total bilirubin.
EAD: early allograft dysfunction, HVFi: hepatic vein flow index

HV flow assessment would be important in predicting graft
function given that inflow of the new graft includes the hepatic
artery and portal vein, and outflow includes only the HVs. Suboptimal outflow may be due to suboptimal inflow or graft congestion, both of which are ominous signs for postoperative

graft function. Previous correlation studies between intraoperative flow assessment of hepatic artery or portal vein and postoperative graft function were unable to show consistency in
their correlation.30-32 Takahashi et al. reported that this inconsistency between flow and graft function might be because of a
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Table 4
Multivariable Logistic Regression for EAD

HVFi syst
Donor age
CIT
HVFi dia
Donor age
CIT

OR (95% CI)

p Value

0.313 (0.125-0.783)
1.040 (0.988-1.090)
1.010 (0.998-1.010)
0.136 (0.0285-0.646)
1.050 (0.996-1.110)
1.010 (0.998-1.020)

0.013
0.135
0.139
0.012
0.071
0.118

Abbreviations: CI, confidence interval; CIT, cold ischemic time; EAD, early
allograft dysfunction; HVFi dia, hepatic vein flow index in diastole; HVFi sys,
hepatic vein flow index in systole; OR, odds ratio.

Table 5
ICC for HVFi sys and HVFi dia

Inter-rater
Intrarater

Group

ICC

95% CI

HVFi sys
HVFi dia
HVFi sys
HVFi dia

0.997
0.993
0.998
0.998

(0.995, 0.998)
(0.988, 0.996)
(0.997, 0.999)
(0.996, 0.999)

Abbreviations: CI, confidence interval; HVFi dia, hepatic vein flow index in
diastole; HVFi sys, hepatic vein flow index in systole; ICC, Intraclass
Correlation Coefficient.

lack of consistency in the timing of measurements,30 and
the authors’ data also showed that tendency. Another reason for this inconsistency could be explained by hepatic
arterial buffer response. It is the ability of the hepatic
artery to produce compensatory flow changes in response
to changes in portal venous flow. This buffer system would
adjust flows in hepatic artery and portal vein; however, it
is not reported to affect HVF.17
This study was the first to assess HV flow (ie, outflow of the
new graft) quantitatively using intraoperative TEE and its correlation with graft function. Reproducibility is the key for this
new method of HVFi measurement, so choosing an easily
measurable index is very important. The authors chose peak
velocity over velocity time integral because of its simple measurement. The authors also devised HVFi, which is the ratio of
HVF to graft weight. This HVFi worked better for predicting
graft function. The authors assessed graft function in three
ways: EAD, acute rejection, and TIME t-bil. EAD is a composite outcome that is reported to be correlated with graft loss
and patient mortality.19,20 Also, the authors chose trend of t-bil
over trend of INR or platelet as an index of postoperative graft
function because INR and platelet count can be affected by
postoperative transfusion, as seen in differences of time to normalize t-bil, INR, and platelet in groups with EAD in Table 1.
Not surprisingly, EAD, acute rejection, and TIME t-bil were
significantly related. Obtaining the optimal modified TEE
transgastric HV view is mandatory to measure HVF precisely
in the neohepatic phase. Timing is vital; the retractor should
be taken off for better alignment of the IVC and new graft, and
perhaps before fascia closure, because the measurement might
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affect surgical decisions. Precise measurement of the HV
radius is crucial because this number will be squared and affect
more than HV velocity. Thus, obtaining images with clear
margin HV is crucial.
At the authors’ transplant institute, TEE is routine unless
there is absolute contraindication; however, only cardiac
trained anesthesiologists are able to pay attention to quantitative HV flow during OLT. This might be because cardiac
anesthesiologists are familiar with assessing HV and IVC
with TEE when they are confirming venous cannula position in cardiac surgeries. This emphasizes the importance
of interaction between cardiac anesthesiologists and transplant anesthesiologists. The authors believe that TEE-modified transgastric HV view is encouraged because it is
relatively easy to obtain with appropriate training, as
86.7% of the images were satisfactory for HVF assessment
in this study; however, TEE probe manipulation should be
minimized out of concern for esophageal varices and portal
hypertensive gastropathy. For this reason, the measurement
should be performed only for advanced TEE-boarded
physicians. Alternative ultrasound imaging directly on the
surface of the liver potentially could give similar measurements without TEE-related risks.
This study had some limitations. First, the limitations of a
single center prospective study apply. Second, the authors
assumed that the cross-section of HV was a circle, which
might not always be true. Lastly, the authors’ reproducibility
assessment was done on the same images and might not be the
best assessment for reproducibility of HVF in each hemodynamic situation. The rationale for choosing the same images
for HVF assessment was that HVF theoretically is stable
regardless of the sample volume location given the concept
“continuity of flow” as long as hemodynamic situation is the
same. The authors were able to say that reproducibility of
HVF measurement for the same images is reasonable as long
as Doppler image quality is optimal. Also, angulation of PWD
and HV might have to be considered, even though efforts were
made to align these two lines.
The authors’ methodology of measuring HVF using TEE
(both in systole and diastole) has the potential to predict the
postoperative graft function before skin closure and postoperative management. The work that has been done in the current
study was to propose a cut-off value for the novel HVFi score;
however, the predictive value of this score is yet to be tested.
In future study to determine the predictive value of the HVFi,
this cut-off should be applied to a different sample in a prospective fashion. This would involve recruiting a sample of
patients for planned OLT. First HVFi would be measured for
all participants and a risk of EAD calculated. The risk of EAD
in the study population based on HVFi then would be compared with actual EAD. Then, the predictive value of the HVFi
also could be compared with a range of other predictive factors
(eg, MELD, duration of surgery, and WIT to determine if addition of HVFi improves the risk estimate). The authors also
might be able to discuss treatment options based on measured
HVFi and other clinical information including low inflow and
graft congestion.
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The authors hope that this study will encourage transplant
anesthesiologists to pay attention to graft flows with TEE in
OLT.
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